Inventor · disambiguated record
Amjad Ali
Also filed as: ALI AMJAD
70 granted patents·14 pending applications·306 citations·filing 1997–2025
98Inventor score
Files withMERCK SHARP & DOHME40ALI AMJAD17MERCK SHARP & DOHME LLC13MERCK & CO INC4UNIV KING FAHD PET & MINERALS3
Top patents by PatentIndex Score
84 records- 0195US7652049B2CETP inhibitorsMERCK & CO INC·Filed 2005·Granted Jan 26, 2010·54 cites·54 claims
- 0294US7915271B21,3-oxazolidin-2-one derivatives useful as CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Mar 29, 2011·15 cites·21 claims
- 0393US7947664B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted May 24, 2011·28 cites·18 claims
- 0492US8053455B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2011·Granted Nov 8, 2011·28 cites·20 claims
- 0592US7910592B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Mar 22, 2011·13 cites·15 claims
- 0690US7737295B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Jun 15, 2010·15 cites·16 claims
- 0789US7781426B2CETP inhibitorsMERCK SHARP & DOHME·Filed 2006·Granted Aug 24, 2010·18 cites·12 claims
- 0888US11312719B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME·Filed 2019·Granted Apr 26, 2022·4 cites·25 claims
- 0988US7625937B21H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2007·Granted Dec 1, 2009·11 cites·21 claims
- 1086US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 1184US8354454B2Prodrugs of oxazolidinone CETP inhibitorsMERCK SHARP & DOHME·Filed 2009·Granted Jan 15, 2013·7 cites·17 claims
- 1283US10472347B2Aminopyrazine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2015·Granted Nov 12, 2019·5 cites·19 claims
- 1383US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 1483US8334290B2CETP inhibitorsALI AMJAD·Filed 2006·Granted Dec 18, 2012·5 cites·12 claims
- 1582US8865707B2Cholesteryl ester transfer protein inhibitorsALI AMJAD·Filed 2006·Granted Oct 21, 2014·6 cites·8 claims
- 1682US8735435B2CETP inhibitorsALI AMJAD·Filed 2009·Granted May 27, 2014·5 cites·9 claims
- 1781US12263171B27-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 1, 2025·2 cites·20 claims
- 1881US10011615B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist propertiesMERCK SHARP & DOHME·Filed 2017·Granted Jul 3, 2018·3 cites·14 claims
- 1981US9145391B2Bipyridylaminopyridines as Syk inhibitorsDESCHENES DENIS·Filed 2012·Granted Sep 29, 2015·10 cites·13 claims
- 2080US7834042B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted Nov 16, 2010·3 cites·12 claims
- 2179US10123995B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 2279US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 2379US9708347B2Heterobicyclo-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·3 cites·15 claims
- 2479US8623846B2Diazeniumdiolate cyclohexyl derivativesALI AMJAD·Filed 2011·Granted Jan 7, 2014·2 cites·15 claims
- 2579US7745657B2D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligandsMERCK SHARP & DOHME·Filed 2006·Granted Jun 29, 2010·4 cites·11 claims
- 2677US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 2776US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 2875US10822338B2Substituted aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 3, 2020·2 cites·17 claims
- 2975US7880014B2Angiotensin II receptor antagonistsMERCK SHARP & DOHME·Filed 2007·Granted Feb 1, 2011·2 cites·7 claims
- 3074US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 3173US9676780B2Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist propertiesMERCK SHARP & DOHME·Filed 2013·Granted Jun 13, 2017·2 cites·15 claims
- 3273US8440702B21,3-oxazolidin -2-one derivatives useful as CETP inhibitorsALI AMJAD·Filed 2011·Granted May 14, 2013·1 cites·21 claims
- 3373US7282591B21h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2003·Granted Oct 16, 2007·5 cites·2 claims
- 3472US8648058B2Diazeniumdiolate cyclopentyl derivativesALI AMJAD·Filed 2011·Granted Feb 11, 2014·2 cites·18 claims
- 3572US8361994B2Primary amine diazeniumdiolate heterocyclic derivativesMERCK SHARP & DOHME·Filed 2012·Granted Jan 29, 2013·2 cites·32 claims
- 3672US8106034B2Angiotensin II receptor antagonistsALI AMJAD·Filed 2009·Granted Jan 31, 2012·1 cites·11 claims
- 3772US2025382300A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 3872US2025197707A1Solvent-based method for making a phase change materialUNIV KING FAHD PET & MINERALS·Filed 2025·Application pending·0 cites
- 3971US12060357B29-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2022·Granted Aug 13, 2024·0 cites·28 claims
- 4071US7411073B2Selective non-steroidal glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2004·Granted Aug 12, 2008·5 cites·11 claims
- 4170US8119806B2Cicletanine derivativesALI AMJAD·Filed 2009·Granted Feb 21, 2012·1 cites·12 claims
- 4269US10344039B2Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their useMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·17 claims
- 4369US9073929B2Aldosterone synthase inhibitorsHOYT SCOTT B·Filed 2012·Granted Jul 7, 2015·3 cites·20 claims
- 4469US7732432B217-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulatorsMERCK SHARP & DOHME·Filed 2004·Granted Jun 8, 2010·4 cites·10 claims
- 4569US2025387397A1Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their useMERCK SHARP & DOHME LLC·Filed 2025·Application pending·0 cites
- 4668US9745282B2Indoline compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 29, 2017·1 cites·10 claims
- 4768US8193365B2CETP inhibitorsALI AMJAD·Filed 2010·Granted Jun 5, 2012·1 cites·12 claims
- 4867US12275885B2Doped phase change material and method of preparation thereofUNIV KING FAHD PET & MINERALS·Filed 2022·Granted Apr 15, 2025·0 cites·13 claims
- 4965US12497403B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 16, 2025·0 cites·19 claims
- 5063US8252825B2Angiotensin II receptor antagonistsALI AMJAD·Filed 2008·Granted Aug 28, 2012·0 cites·3 claims
Showing the top 50 of 84 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →